The BioIntegrate™ Process
BioIntegrate™ only only uses human umbilical cord derived stem cellular tissues. These umbilical cord tissue donations come from consenting, disease-free, healthy donors.
BioIntegrate’s™ human umbilical cord tissue regenerative medicine products contain mesenchymal stem cellular tissues that are safe and provide a reliable source for physicians. This therapy is non-invasive for donors and patients, and because it is not surgery, it avoids the risks of surgery such as infection, blood clot and the recovery period.
The tissue is obtained from safe, reliable hospital sources with informed donor consent and strict ethical protocols. The tissues are taken during a non-invasive, simple procedure. Umbilical cord donation is regulated by the American Association of Tissue Banks (AATB) for quality, safety and ethics. The tissues are sourced from healthy donor volunteers who are stringently screened for pathogens in order to assure the product is safe.
Process for Cord Tissue Donation
BioIntegrate’s™ High Safety Standards:
All BioIntegrate’s™ non-embryonic tissue products are obtained from C-section deliveries from normal, full-term pregnancies and consenting donors. All the tissues obtained are screened under AATB standards in order to assure the highest quality product.
Comprehensive medical and social histories of the donors are taken by healthcare technicians along with comprehensive blood testing.